FibroGen (FGEN)

• Market cap: $29.7M
• 1 day: -3.89%
• 5 days: -12.46%
• 1 month: -22.70%
• 3 months: -46.08%
• 6 months: -26.22%
• Year to date: -44.40%
• 1 year: -79.98%
• 5 years: -99.10%
• 10 years: -99.05%
• Sector: Healthcare
• Industry: Biotechnology

Fund manager confidence

Based on 2024 Q4 regulatory filings by fund managers ($100M+ AUM)

300% more call options, than puts

Call options by funds: $336K | Put options by funds: $84K

0% more funds holding in top 10

Funds holding in top 10: 1 [Q3] → 1 (+0) [Q4]

0% less capital invested

Capital invested by funds: $19.5M [Q3] → $19.5M (-$54.4K) [Q4]

4% less funds holding

Funds holding: 72 [Q3] → 69 (-3) [Q4]

10.9% less ownership

Funds ownership: 47.42% [Q3] → 36.51% (-10.9%) [Q4]

21% less first-time investments, than exits

New positions opened: 11 | Existing positions closed: 14

36% less repeat investments, than reductions

Existing positions increased: 14 | Existing positions reduced: 22

Research analyst outlook

1 Wall Street Analyst provided 1 year price targets over the past 3 months

• Low target: $10 3,298% upside
• Avg. target: $10 3,298% upside
• High target: $10 3,298% upside

1 analyst rating

• positive: 1 100%
• neutral: 0 0%
• negative: 0 0%

HC Wainwright & Co. Joseph Pantginis 17% 1-year accuracy 73 / 418 met price target

3,298% upside $10

Buy Reiterated

18 Mar 2025